REDUCE MRSA: From Novel Idea to 74,000 Patients

Author – John Jernigan, M.D., director of CDC’s Office of Prevention Research and Evaluation and head of CDC’s Prevention Epicenters Program. I am excited to announce the results of the REDUCE MRSA study which evaluated three current strategies f…

Making Infection Prevention “Simple”

Susan Huang, M.D., M.P.H., lead author of the REDUCE MRSA study and Associate Professor at the University of California Irvine School of Medicine and Medical Director of Epidemiology and Infection Prevention at UC Irvine Health For years, we have searc…

What People Are Saying About the REDUCE MRSA Trial

The REDUCE MRSA trial was published in today’s New England Journal of Medicine and took place in two stages from 2009-2011. A multidisciplinary team from the University of California, Irvine, Harvard Pilgrim Health Care Institute, Hospital Corporatio…

Methicillin-Resistant Staphylococcus aureus (MRSA)

 Methicillin-resistant S. aureus is a variant of S. aureus which is considered to be resistant to all beta-lactam antibiotics (including penicillins, cephalosporins, and cephamicins). It may also be resistant to […]

Controlling MRSA In The Community Setting

Community-Associated MRSA has emerged in the general population as a frequent cause of skin infections (boils, abscesses, furuncles, etc.), and occasionally more invasive infections in healthy individuals lacking the usual […]